The aim of this study was to longitudinally compare the clinical and radiological outcomes of anatomical total shoulder arthroplasty (aTSA) up to long-term follow-up, when using cemented keel, cemented peg, and hybrid cage peg glenoid components and the same humeral system. We retrospectively analyzed a multicentre, international clinical database of a single platform shoulder system to compare the short-, mid-, and long-term clinical outcomes associated with three designs of aTSA glenoid components: 294 cemented keel, 527 cemented peg, and 981 hybrid cage glenoids. Outcomes were evaluated at 4,746 postoperative timepoints for 1,802 primary aTSA, with a mean follow-up of 65 months (24 to 217).Aims
Methods
Little guidance exists regarding the minimum screw length and number necessary to achieve fixation with reverse shoulder arthroplasty (rTSA). The goal of this study is to quantify the pre- and post-cyclic baseplate displacements associated with two baseplate designs of different sizes using multiple screw lengths and numbers in a low density polyurethane bone substitute model. The test was conducted according to ASTM F 2028–17. The baseplate displacements of standard and small reverse shoulder constructs (Equinoxe, Exactech, Inc.) were quantified in a 15pcf polyurethane block (Pacific Research, Inc.) before and after cyclic testing with an applied load of 750N for 10,000 cycles. Baseplates were constructed using 2 or 4 screws with 3 different poly-axial locking compression screw lengths: 4.5×18mm, 4.5×30mm, and 4.5×46mm. Five of each configuration were tested for a total of 30 specimens for each baseplate. A two-tailed, unpaired student's t-test (p<0.05) compared baseplate displacements before and after cyclic loading in both the superior-inferior (S/I) and anterior-posterior (A/P) directions. The standard and small results were then compared.Introduction
Methods
The clinical impact of radiolucent glenoid lines is controversial, where the presence of a radiolucent glenoid lines has been suggested to be an indicator of clinical glenoid loosening. The goal of this database analysis is to quantify and compare the pre- and post-operative outcomes of 427 patients who received a primary aTSA with one specific prosthesis and were sorted based upon the radiographic presence of a radiolucent glenoid line at latest clinical followup. 427 patients (mean age: 67.0yrs) with an average follow-up of 49.4 months was treated with aTSA for OA by 14 fellowship trained orthopaedic surgeons. Of these 427 patients, 293 had a cemented keel glenoids (avg follow-up = 50.8 months) and 134 had a cemented pegged glenoids (avg follow-up = 48.7 months). Cemented peg and keel glenoid patients were analyzed separately and also combined into 1 cohort: 288 patients (158 female, avg: 68.7 yrs; 130 male, avg: 64.9 yrs) did not have a radiolucent glenoid line (avg follow-up = 46.9 months); whereas, 139 patients (83 female, avg: 68.5 yrs; 56 male, avg: 64.6 yrs) had a radiolucent glenoid line (avg follow-up = 54.4 months). Outcomes were scored using SST, UCLA, ASES, Constant, and SPADI metrics; active ROM also measured. A two-tailed, unpaired t-test identified differences (p<0.05) in pre-operative, post-operative, and pre-to-post improvements.Introduction
Methods
Due to the predictability of outcomes achieved with reverse shoulder arthroplasty (rTSA), rTSA is increasingly being used in patients where glenoid fixation is compromised due to presence of glenoid wear. There are various methods to achieve glenoid fixation in patients with glenoid wear, including the use of bone grafting behind the glenoid baseplate or the use of augmented glenoid baseplates. This clinical study quantifies clinical outcomes achieved using both techniques in patients with severe glenoid wear at 2 years minimum follow-up. 80 patients (mean age: 71.6yrs) with 2 years minimum follow-up were treated by 7 fellowship trained orthopaedic surgeons using rTSA with bone graft behind the baseplate or rTSA with an augmented glenoid baseplate in patients with severe posterior glenoid wear. 39 rTSA patients (14 female, avg: 73.1 yrs; 25 male, avg: 71.5 yrs) received an augmented glenoid (cohort composed of 24 patients with an 8° posterior augment baseplate and 15 patients with a 10° superior augment baseplate) for treatment of CTA, RCT, and OA with a medially eroded scapula. 41 rTSA patients (27 female, avg: 73.0 yrs; 14 male, avg: 66.9 yrs) received glenoid bone graft (cohort composed of 5 patients with allograft and 36 patients with autograft) for treatment of CTA, RCT, and OA with a medially eroded scapula. Outcomes were scored using SST, UCLA, ASES, Constant, and SPADI metrics; active abduction, forward flexion, and internal/external rotation were also measured to quantify function. Average follow-up was 31.2 months (augment 28.3; graft 34.1). A two-tailed, unpaired t-test identified differences (p<0.05) in pre-operative, post-operative, and pre-to-post improvements.Introduction
Methods
Posterior glenoid wear is common with glenohumeral osteoarthritis. To correct posterior wear, surgeons may eccentrically ream the anterior glenoid to restore version. However, eccentric reaming undermines prosthesis support by removing unworn anterior glenoid bone, compromises cement fixation by increasing the likelihood of peg perforation, and medializes the joint line which has implications on joint stability. To conserve bone and preserve the joint line when correcting glenoid version, manufacturers have developed posterior augment glenoids for aTSA and rTSA applications. This clinical study quantifies outcomes achieved using posteriorly augmented aTSA/rTSA glenoid implants in patients with severe posterior glenoid wear at 2 years minimum follow-up. 47 patients (mean age: 68.7yrs) with 2 years minimum follow-up were treated by 5 fellowship trained orthopaedic surgeons using either 8° posteriorly augmented aTSA/rTSA glenoid components in patients with severe posterior glenoid wear. 24 aTSA patients received posteriorly augmented glenoids (65.8 yrs; 7F/17M) for OA and 23 rTSA patients received posteriorly augmented glenoids (71.8 yrs; 9F/14M) for treatment of CTA and OA. Outcomes were scored using SST, UCLA, ASES, Constant, and SPADI metrics; active abduction, forward flexion, and external rotation were also measured to quantify function. Average follow-up was 27.5 months (aTSA 29.4; rTSA 25.5). A two-tailed, unpaired t-test identified differences (p<0.05) in pre-operative, post-operative, and pre-to-post improvements.Introduction
Methods
Posterior glenoid wear is common in glenohumeral osteoarthritis. Tightening of the subscapularis causes posterior humeral head subluxation and a posterior load concentration on the glenoid. The reduced contact area causes glenoid wear and potentially posterior instability. To correct posterior wear and restore glenoid version, surgeons may eccentrically ream the anterior glenoid to re-center the humeral head. However, eccentric reaming undermines prosthesis support by removing unworn anterior glenoid bone, compromises cement fixation by increasing the likelihood of peg perforation, and medializes the joint line which has implications on joint stability. To conserve bone and preserve the joint line when correcting glenoid version, manufacturers have developed posterior augment glenoids. This study quantifies the change in rotator cuff muscle length (relative to a nonworn/normal shoulder) resulting from three sizes of posterior glenoid defects using 2 different glenoids/reaming methods: 1) eccentric reaming using a standard (nonaugmented) glenoid and 2) off-axis reaming using an 8, 12, and 16° posterior augment glenoid. A 3-D computer model was developed in Unigraphics (Siemens, Inc) to simulate internal/external rotation and quantify rotator cuff muscle length when correcting glenoid version in three sizes of posterior glenoid defects using posterior augmented and non-augmented glenoid implants. Each glenoid was implanted in a 3-D digitized scapula and humerus (Pacific Research, Inc); 3 sizes (small, medium, and large) of posterior glenoid defects were created in the scapula by posteriorly shifting the humeral head and medially translating the humeral head into the scapula in 1.5 mm increments. Five muscles were simulated as three lines from origin to insertion except for the subscapularis which was wrapped. After simulated implantation in each size glenoid defect, the humerus was internally/externally rotated from 0 to 40° with the humerus at the side. Muscle lengths were measured as the average length of the three lines simulating each muscle at each degree of rotation and compared to that at the corresponding arm position for the normal shoulder without defect to quantify the percentage change in muscle length for each configuration.Introduction
Methods
This study provides recommendations on the position
of the implant in reverse shoulder replacement in order to minimise
scapular notching and osteophyte formation. Radiographs from 151
patients who underwent primary reverse shoulder replacement with
a single prosthesis were analysed at a mean follow-up of 28.3 months
(24 to 44) for notching, osteophytes, the position of the glenoid
baseplate, the overhang of the glenosphere, and the prosthesis scapular
neck angle (PSNA). A total of 20 patients (13.2%) had a notch (16 Grade 1 and four
Grade 2) and 47 (31.1%) had an osteophyte. In patients without either
notching or an osteophyte the baseplate was found to be positioned
lower on the glenoid, with greater overhang of the glenosphere and
a lower PSNA than those with notching and an osteophyte. Female patients
had a higher rate of notching than males (13.3% Based on these findings we make recommendations on the placement
of the implant in both male and female patients to avoid notching
and osteophyte formation. Cite this article:
